PILOPINE HS Drug Patent Profile
✉ Email this page to a colleague
When do Pilopine Hs patents expire, and when can generic versions of Pilopine Hs launch?
Pilopine Hs is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in PILOPINE HS is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pilopine Hs
A generic version of PILOPINE HS was approved as pilocarpine hydrochloride by PADAGIS US on November 16th, 2004.
Summary for PILOPINE HS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Patent Applications: | 3,839 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PILOPINE HS at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PILOPINE HS
US Patents and Regulatory Information for PILOPINE HS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon | PILOPINE HS | pilocarpine hydrochloride | GEL;OPHTHALMIC | 018796-001 | Oct 1, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |